Amplify Surgical, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$421Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
166clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Dualx and Dualportal $36K associated (2023-2025)
- Dual-X $23K associated (2023-2025)
- Dualportal $12K associated (2023-2025)
- Dualx and Dual Portal $6,944 associated (2023-2025)
- Dual-X Portal $5,700 associated (2023-2025)
- Dula-X $2,345 associated (2023-2025)
- Dualx $1,019 associated (2023-2025)
- Dualportal and Dualx $500 associated (2023-2025)
- Dualx and Dulaportal $112 associated (2023-2025)
- Dulax and Dualportal $106 associated (2023-2025)
- Dualx and Dealportal $92.09 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Don Park | Orange, CA | Orthopaedic Surgery of The Spine | $86,002.44 |
| Ki-Eun Chang | Providence, RI | Neurological Surgery | $30,227.13 |
| Brian Kwon | Waltham, MA | Orthopaedic Surgery | $24,490.68 |
| Ankit Mehta | Boston, MA | Surgery | $23,063.18 |
| Andrew Chung | Los Angeles, CA | Orthopaedic Surgery | $20,289.23 |
| Jang Yoon | San Francisco, CA | Neurological Surgery | $18,522.89 |
| Samuel Cho | New York, NY | Orthopaedic Surgery | $17,278.32 |
| Major Burch | Dawsonville, GA | Orthopaedic Surgery | $16,355.72 |
| Kaku Barkoh | Kingwood, TX | Orthopaedic Surgery of The Spine | $15,697.28 |
| Sergio Mendoza Lattes | Durham, NC | Orthopaedic Surgery | $14,731.85 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.